comprehensive -WSS

comprehensive

author：focus 2025-10-01 12:11:27 - browse：556

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Virtual Event: March of the Biosimilars

WSS

Physicians and social media: If you see something, say something?

Guardant Health colon cancer test endorsed by FDA advisory panel

Congress: Prevent baby formula shortages by passing a new bill

UnitedHealth increases loan offers after Change Healthcare outage

Unmasking the 'centricity' illusion in clinical trials

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

explore

comprehensive

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Gene editing the human germline: What are the risks?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Colonoscopy prep: Liquid

United colonoscopy coverage change 'may cost lives,' doctors say

Intermittent fasting comes with a heart risk? Not so fast

Moonlake's readout produced a cash windfall. Risks remain

Louisiana bill approved classifying abortion pills as controlled substances

After affirmative action ruling, medical educators look to 'holistic review'

Orchard's therapy for neuron disease in children wins FDA approval

focus

Positive childhood experiences can help future health

Why we need mandatory labeling of GMO products

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Stop the failed accountable care organization experiment

UnitedHealth increases loan offers after Change Healthcare outage

Beyond aggravation: Constipation is an American epidemic

knowledge

leisure time

hotspot

knowledge